Key Takeaways
- • Basalt Health raised $20 million in Series A funding led by New Enterprise Associates (NEA), with participation from returning investors Frist Cressey Ventures and 25m Health, bringing total capital raised to approximately $24.5 million.
- • The AI platform reduced referral processing time by 86% at Lifepoint Health and will scale across 62 ScionHealth hospitals by the end of 2026, addressing a $17 billion annual market opportunity in avoidable readmission costs.
- • Basalt automates post-acute care placement by ingesting referrals via fax, portal, or direct EMR integration and matching patients to appropriate facilities based on clinical criteria, replacing a manual process where case managers typically send 70-page packets to 6.6 facilities per placement.
- • Founder and CEO Ben Hackett, formerly at Accolade for nearly a decade, launched Basalt in 2024 to streamline administrative workflows and free clinicians to focus on patient care rather than document management.
- • The platform handles the full admissions workflow including benefits verification and prior authorization processing, moving beyond simple document transfer to enable "fast, consistent, and defensible placement decisions."
Summary
Basalt Health, an AI-powered post-acute care placement platform, announced a $20 million Series A financing led by return investor NEA, with participation from existing backers Frist Cressey Ventures and 25m Health. The round brings the Nashville-based company's total fundraising to approximately $24.5 million since its 2024 founding.
The company targets a systemically inefficient market: approximately 14 million patients annually enter post-acute care through a largely unchanged manual referral process. Case managers typically fax lengthy clinical packets to multiple facilities (averaging 6.6 per placement) and await responses, creating delays and clinical mismatches that the company estimates contribute to $17 billion in avoidable annual readmission costs. Basalt's platform reads incoming referrals in real time—whether received via fax, portal, or direct EMR integration—evaluates them against facility clinical criteria, and supports downstream workflows including admissions, benefits verification, and prior authorizations.
Early validation comes from Lifepoint Health, where Basalt achieved an 86% reduction in median referral processing time. The platform is slated to scale across 62 ScionHealth hospitals by year-end 2026. CEO Ben Hackett, who spent nearly a decade at Accolade before founding Basalt, designed the platform to integrate seamlessly into existing care team workflows. "Case managers are still sending 70-page packets and waiting for responses, while patients remain stranded in hospital beds," Hackett said in the announcement. His background—his mother and grandmother were nurses—informed the mission of reducing administrative burden that pulls clinicians away from direct patient care.
The funding underscores investor confidence in automation solutions targeting healthcare's administrative inefficiencies, particularly in high-volume, high-cost care transitions where workflow delays directly impact patient outcomes and system costs.
The company targets a systemically inefficient market: approximately 14 million patients annually enter post-acute care through a largely unchanged manual referral process. Case managers typically fax lengthy clinical packets to multiple facilities (averaging 6.6 per placement) and await responses, creating delays and clinical mismatches that the company estimates contribute to $17 billion in avoidable annual readmission costs. Basalt's platform reads incoming referrals in real time—whether received via fax, portal, or direct EMR integration—evaluates them against facility clinical criteria, and supports downstream workflows including admissions, benefits verification, and prior authorizations.
Early validation comes from Lifepoint Health, where Basalt achieved an 86% reduction in median referral processing time. The platform is slated to scale across 62 ScionHealth hospitals by year-end 2026. CEO Ben Hackett, who spent nearly a decade at Accolade before founding Basalt, designed the platform to integrate seamlessly into existing care team workflows. "Case managers are still sending 70-page packets and waiting for responses, while patients remain stranded in hospital beds," Hackett said in the announcement. His background—his mother and grandmother were nurses—informed the mission of reducing administrative burden that pulls clinicians away from direct patient care.
The funding underscores investor confidence in automation solutions targeting healthcare's administrative inefficiencies, particularly in high-volume, high-cost care transitions where workflow delays directly impact patient outcomes and system costs.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.